Nova Patents
PL337362A1

Treatment of diabetes by means of thiazolydinone and metformin

Abstract

A method for the treatment and/or prophylaxis of diabetes mellitus, conditions associated with diabetes mellitus and certain complications thereof, in a mammal which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and a biguanide antihyperglycaemic agent, to a mammal in need thereof and a pharmaceutical composition comprising an insulin sensitiser and a biguanide antihyperglycaemic agent.

Term

Term ended

Projected expiry passed 15 June 2018, 8.3 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

90 members in 44 offices

This recordMember, by publication datePriority claim34 more offices are in the list below

Priority claims11

Priority claims
DocumentOfficeKindDate
9712857United KingdomA
9712857United KingdomA
9806706United KingdomA
9806706United KingdomA
9803690European Patent Office (EPO)W
9803690European Patent Office (EPO)W
9712857–––
9806706–––
GB19970012857–––
GB19980006706–––
WO1998EP03690–––

Members90

Family members, oldest first
DocumentOfficeKind
GB9712857D0United KingdomD0
GB9806706D0United KingdomD0
CA2294582A1CanadaA1
CA2549864A1CanadaA1
WO9857634A1World Intellectual Property Organization (WIPO)A1
AU8539398AAustraliaA
PE83199A1PeruA1
NO20063000LNorwayL
NO20090846LNorwayL
NO996266D0NorwayD0
NO996266LNorwayL
ZA985238BSouth AfricaB
ID23372AIndonesiaA
TR199903057T2TürkiyeT2
EP0996444A1European Patent Office (EPO)A1
CN1260716AChinaA
BR9810172ABrazilA
PL337362A1This recordPolandA1
EA200000041A1Eurasian Patent Organization (EAPO)A1
UY25049A1UruguayA1
BG104060ABulgariaA
SK179299A3SlovakiaA3
AR012995A1ArgentinaA1
AR012998A1ArgentinaA1
HU0002668A2HungaryA2
HK1028193A1Hong Kong, ChinaA1
KR20010013844ARepublic of KoreaA
IL133142D0IsraelD0
CZ9904578A3CzechiaA3
HU0002668A3HungaryA3
US2002004515A1United States of AmericaA1
JP2002504137AJapanA
AU1011902AAustraliaA
US2002137772A1United States of AmericaA1
NZ501260ANew ZealandA
DZ2520A1AlgeriaA1
EA003144B1Eurasian Patent Organization (EAPO)B1
IN189722BIndiaB
US2003109553A1United States of AmericaA1
CN1114404CChinaC
CN1429551AChinaA
NZ515554ANew ZealandA
TW565449BTaiwan Province of ChinaB
OA11516AAfrican Intellectual Property Organization (OAPI)A
AP1279AAfrican Regional Intellectual Property Organization (ARIPO)A
NZ520542ANew ZealandA
UA68352C2UkraineC2
MA26512A1MoroccoA1
AU778947B2AustraliaB2
US2005059706A1United States of AmericaA1
CN1230171CChinaC
US2006100247A1United States of AmericaA1
BG109398ABulgariaA
BG64818B1BulgariaB1
CN1781483AChinaA
IL133142AIsraelA
IL173650D0IsraelD0
KR20060105005ARepublic of KoreaA
SA1617B1Saudi ArabiaB1
US2007004780A1United States of AmericaA1
KR100666591B1Republic of KoreaB1
EP0996444B1European Patent Office (EPO)B1
AT355840TAustriaT
DE69837261D1GermanyD1
EP1787646A2European Patent Office (EPO)A2
MY129897AMalaysiaA
PT996444EPortugalE
DK0996444T3DenmarkT3
PL195136B1PolandB1
PL195140B1PolandB1
SI0996444T1SloveniaT1
CN101040854AChinaA
EP1787646A3European Patent Office (EPO)A3
CZ298469B6CzechiaB6
ES2284212T3SpainT3
NL300288I1Netherlands (Kingdom of the)I1
DE69837261T2GermanyT2
DE122007000054I1GermanyI1
SK286029B6SlovakiaB6
NO324993B1NorwayB1
LU91356I2LuxembourgI2
CA2294582CCanadaC
US2008090881A1United States of AmericaA1
NO2008003I1NorwayI1
EG24199AEgyptA
CN100431540CChinaC
NO326958B1NorwayB1
NL300288I2Netherlands (Kingdom of the)I2
HU226960B1HungaryB1
NO2008003I2NorwayI2